Chinese Journal of Pharmacovigilance ›› 2013, Vol. 10 ›› Issue (3): 536-539.

Previous Articles    

France and Canada Drug Regulatory Agencies and Implication

ZHANG Hao1, DONG Duo2, CHENG Gang2*   

  1. 1.School of Business Administration, Shenyang Pharmaceutical University, Liaoning Shenyang 110016, China;
    2.Center for Drug Reevaluation, CFDA, Beijing 100045, China
  • Received:2013-08-12 Revised:2016-03-09 Online:2013-09-08 Published:2016-03-09

Abstract: Drug regulatory agency is the main body of implementing market regulation, the setting pattern and organizational system directly affects the efficiency of government regulation and the development of the pharmaceutical market's vitality. In this article France and Canada drug regulatory agencies were selected the research object. By searching their drug regulatory official websites and related literatures, we summarized the main responsibility of the drug administration, organization and supervisor and compared with drug regulatory institution setting and function of our country. The comments and suggestions were put forward for the construction and development of China's drug regulatory system.

Key words: France, Canada, regulatory agency, implication

CLC Number: